VPI-2690B

CAT: 0804-HY-P991254Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-P991254Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
VPI-2690B is a human monoclonal antibody (mAb) targeting Integrin aVb3. VPI-2690B inhibits TGF-β signaling. VPI-2690B can be used in Diabetic nephropathies research[1].
UNSPSC
12352203
Target
Integrin; TGF-β Receptor
Related Pathways
Cytoskeleton; TGF-beta/Smad
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Smiles
[VPI-2690B]
References & Citations
[1]Park CH, et al. TGF-β Inhibitors for Therapeutic Management of Kidney Fibrosis. Pharmaceuticals (Basel) . 2022 Nov 29;15 (12) :1485.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Related Products

CatalogName

Alternative Products

CatalogName
T9901A-1664-01VPI-2690B
HY353116-01Research Grade Anti-Human CD221/IGF1R (VPI-2690B)
A136403Anti-CD221/IGF1R (VPI-2690B) Biosimilar (Monoclonal, IgG)
EPV0052Porcine VPI ELISA Kit
EMV0052Mouse VPI ELISA Kit
ERV0052Rat VPI ELISA Kit
EGTV0052Goat VPI ELISA Kit
EBV0052Bovine VPI ELISA Kit
EAV0052Anserini VPI ELISA Kit
EHV0052Human VPI ELISA Kit

Popular Products